ExciteLab Batch 3 alumni, veiio, has successfully closed its initial financing round. Sächsische Beteiligungsgesellschaft mbH (SBG) is investing in the Dresden-based deep-tech startup through its Startup-Lab program. With this fresh capital, veiio will launch its first real-world pilot applications and validate its technology alongside clinical partners.
Since joining ExciteLab, the founding team has been on a strong growth trajectory. In 2025, they gained national recognition as a winner of the prestigious BioInnovate startup competition at Leipzig University. Securing this funding round marks their next major milestone toward market readiness.
Back pain remains one of the most common health issues worldwide, putting immense strain on both patients and healthcare systems. While long-term recovery depends on consistent home exercises, exercising without professional supervision often leads to poor form, reduced therapeutic success, or even increased pain.
veiio tackles this challenge by merging smart textiles with artificial intelligence. The team has developed a smart training shirt featuring high-precision sensors seamlessly integrated into the fabric. These sensors capture 3D body movements in real time, while an embedded AI engine analyzes the data instantly.
The game-changing feature? Direct haptic feedback. If a patient strays from proper biomechanical form, the shirt delivers gentle vibration cues directly to the skin. These impulses act like the corrective touch of a physical therapist, intuitively guiding the user back into alignment.
Far beyond a standard consumer wearable, veiio is building a medical-grade platform that seamlessly connects patients with healthcare professionals:
For Patients: A companion app delivers personalized exercise plans with step-by-step guidance. It tracks progress, boosts motivation, and provides tailored corrective feedback based on sensor data.
For Therapists: A digital dashboard offers physical therapists and doctors complete visibility into home training routines. They can track compliance, analyze form accuracy, and remotely adjust therapy plans based on real data.
With SBG's backing, the Dresden team is now preparing for series production of their sensor shirts and kicking off clinical pilot phases. The goal is clear: enabling safe, effective home therapy while alleviating the burden on overburdened therapy practices.